शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEAspira Pathlab & Diagnostics L· Healthcare ServicesHighNeutral
Announced Fri, 6 Nov, 2026 · 16:50 IST

Standalone quarter ended September 2026: revenue down 22.6 percent; loss after tax 115.95 lakh

Revenue declinedNet loss reportedEBITDA margin compressionEmphasis of matterResults restatedResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Standalone quarter ended 30 September 2026: revenue 626.04 lakh versus 809.28 lakh a year earlier, down 22.6 percent; loss after tax was 115.95 lakh versus a 183.54 lakh profit. Standalone half year to September 2026: revenue 1,242.94 lakh versus 1,334.08 lakh a year earlier; loss after tax was 119.72 lakh versus a 230.49 lakh profit. Unmodified review highlighted three claims totaling 111.50 lakh, with no provision. Prior figures were regrouped.

Likely market impact

Revenue weakness, the quarterly loss and claims without provision raise downside risk and could pressure the share price.

By the numbers

The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.